Although prostate cancer is generally associated with favorable outcomes, metastatic disease remains incurable. Additionally, a subset of individuals with high-risk or metastatic disease are likely to ...

The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry. Rates of actionable genetic alterations were similar in prostate cancer patients ...

A new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans with metastatic prostate cancer uncovered differences in the genomic makeup ...